A new rotational thrombectomy catheter: System design and first clinical experiences by Schmitt, Hans-Erich et al.
CardioVascular 
and Interventional 
Radiology 
9 Springer-Verlag New York, Inc. 1999 Cardiovasc Intervent Radiol (1999) 22:504-509 
LABORATORY INVEST IGAT IONS 
A New Rotational Thrombectomy Catheter: 
System Design and First Clinical Experiences 
Hans-Erich Schmitt, 1 Kurt A. J iger, 2 Augustinus L. Jacob, 1 Helmuth Mohr, 3 
Karl-Heinz Labs, 2 Wolfgang Steinbrich 1 
JDepartment of Diagnostic Radiology, University Hospital Basel, Kantonsspital, CH-4031 Basel, Switzerland 
2Department of Medicine, Division of Angiology, University Hospital Basel, Kantonsspital, CH-4031 Basel, Switzerland 
3Straub Medical, Straubstrasse, CH-7323 Wangs, Switzerland 
Abstract 
Purpose: To describe a new catheter for the percutaneous 
mechanical removal of fresh and organized thrombi, and to 
assess its efficacy and safety in vitro and in vivo. 
Methods: The catheter consists of a coated stainless steel 
spiral that rotates at 40,000 rpm over a guidewire inside the 
whole length of an 8 Fr, single-lumen, polyurethane catheter, 
driving a dual-blade cutting crown. Abraded occlusion ma- 
terial is sucked into the catheter head through distal side 
holes and transported by the spiral into a reservoir at the 
proximal end. The efficacy of the device was tested in 
arterial models and fresh bovine carotid arteries (n = 72). In 
a clinical pilot study 10 patients (8 women, 2 men; mean age 
70.6 ___ 10.1 years) with occlusions of the superficial femoral 
artery (2-12 cm, mean 5.8 cm), not older than 4 weeks, 
underwent thrombectomy with the new catheter. 
Results: In arterial models and bovine cadaver arteries the 
catheter completely removed fresh thrombi. Occlusion ma- 
terial of higher consistency was cut into particles of 100-500 
/xm and transported outside. Thrombectomy was successful 
and vessel patency restored in all 10 patients. The ankle/ 
brachial pressure index significantly (p < 0.0005) in- 
creased from 0.41 _+ 0.18 before intervention to 0.88 _+ 0.15 
after 48 hr and to 0.84 ___ 0.20 after 3 months. Two reocclu- 
sions occurred within 14 days after the intervention. 
Conclusion: Thrombectomy with the new device appears to 
be feasible and safe in patients with acute and subacute 
occlusions of the femoropopliteal rtery. 
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The drawbacks of conventional nonsurgical treatment of 
thrombotic arterial occlusions, such as long procedure time, 
bleeding, vessel wall injury and peripheral embolization, 
have stimulated the development of devices for mechanical 
removal of thrombi in the last decade [1-3]. Several systems 
have entered clinical practice, while others were described as 
prototypes. Each device has its own limitations, including 
restriction to fresh thrombi only, incomplete clot removal, 
vessel walt damage, or design complexity. The ideal instru- 
ment should be wire-guided to avoid vessel perforation, 
remove fresh and organized thrombi, and transport them to 
the outside without risk of peripheral embolization. With this 
aim in view a rotational catheter was constructed and is 
described here for the first time. 
Materials and Methods 
The system has three components: the Rotarex catheter (Straub 
Rotarex, patent pending, Straub Medical, Wangs, Switzerland), a
40 W DC electric motor drive, and an electronic ontrol unit (Fig. 
1A). Inside the whole length of the 8 Fr polyurethane catheter 
rotates acoated stainless teel spiral, which glides over a 0.020-inch 
guidewire (Schneider Europe, Btilach, Switzerland). The catheter 
head consists of two cylinders that fit over each other (Fig. 1B, C). 
The outer rotating cylinder is fixed to the spiral, the inner one is 
attached to the catheter shaft. Each cylinder has two oval slits. The 
blunt tip of the outer cylinder is perforated for the guidewire. 
Catheter and motor drive are connected by a magnetic lutch. The 
motor otates the spiral at 40,000 rpm, resulting in 80,000 cuts/min. 
The high fi'equency of revolution creates anegative pressure at the 
catheter head of 5.8 kPa (=43.5 mmHg). When the catheter is 
activated, soft and solid occlusion material is caught in the slits, 
transported by the spiral to the proximal sideport, and discharged 
into a plastic bag. No additional suction is required. The transport 
of the occlusion material is done exclusively by the rotating spiral. 
The catheter is for one-time use, while the motor drive and the 
connecting cable to the electronic ontrol unit can be sterilized. 
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Fig. 1. A The Straub Rotarex catheter attached to the 
motor drive. B Schematic drawing of the catheter head. 
Note the rotating outer cylinder (in three functional 
positions) gliding over the inner fixed cylinder with its oval 
slits. The guidewire runs inside the transport spiral, which 
is attached to the tip of the perforated head of the outer 
cylinder. C Photograph of the Rotarex catheter head. 
Preclinical Studies 
The catheter was tested in an arterial model made of silicon tubing 
and in fresh bovine carotid arteries. Translucent silicon tubing of 4, 
6, and 8-mm inner diameter and length 15-30 cm served as an 
arterial model, allowing the observation and the video documenta- 
tion of the catheter function. The tubes were bendable to test the 
behavior of the catheter at various angles. The tubing was filled 
with occlusion material of different consistencies: (a) bovine blood 
that was allowed to coagulate for 48 hr or 2 weeks and stored at 
4~ (b) stamp cylinders of "black pudding", a mixture of throm- 
bus, muscle, fat, and connective tissue, 4, 6, and 8 mm thick, and 
15 cm long, simulating organized thrombus; (c) strips of bovine 
arteries (3 cm long, 1 mm broad) sutured intratuminally to the 
vessel wall, imitating intimal flaps. The tubing was clamped at one 
end and connected to an infusion line on the other, where a mixture 
of saline and glycerine could be infused under a continuous pres- 
sure of 120 mmHg. In this infusion tube an 8 Fr sheath (Cook, 
Bjaerverskov, Denmark) was introduced, a 0.020-inch Teflon 
coated guidewire threaded through the occlusion material, and the 
catheter advanced. 
In a second test series (n = 72) the silicon tubing was replaced 
by fresh bovine carotid arteries with an average length of 20 cm and 
a diameter of 6-7 mm. The side branches were ligated and the 
arteries filled with the above-mentioned occlusion material. During 
catheter activation tubes and arteries were either kept straight or 
bent in different angles up to 50 ~ . Occlusion of the arteries was 
achieved by tightening a 5-mm-wide rubber band around the vessel, 
completely interrupting the flow of perfusate. The occlusion was 
passed with the catheter over the wire. All tests were recorded on 
video. The time of catheter activation was recorded, the volume of 
the aspirated fluid measured, and the fluid passed through different 
filters for analysis of particle size. The arteries were cut open and 
examined visually and histologically for remnants of occlusion 
material and possible intimal damage. 
Clinical Studies 
Based on the results of the preclinical tests the institutional review 
board of the Department of Internal Medicine, University Hospital 
Basel, accepted the protocol of a pilot study for the evaluation of 
the device for the treatment of thrombotic occlusions in femoro- 
popliteal arteries in humans. Ten patients (8 women, 2 men; age 
58-87 years, mean 70.6 _+ 10.1 years) with acute or subacute 
occlusion of the femoropopliteal rtery with an estimated age of 
less than 4 weeks and patent proximal segments of lower leg 
vessels, were included in the study. All patients were informed in 
detail about he procedure and gave their written consent. Patients 
with aneurysms of the popliteal artery, severe coagulation distur- 
bances or a history of adverse reactions to contrast media were 
excluded. 
Seven patients suffered from critical ischemia (rest pain) and 
three from peripheral arterial occlusive disease (PAOD) stage II 
(intermittent claudication). The estimated age of the lesions was 
between 2 and 28 days. The mean length of the occluded segments 
was 5.8 cm (range 2-15 cm). The diagnosis was established by 
clinical examination, oscillography, Doppler pressure recordings, 
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duplex sonography [4], and digital subtraction arteriography. Lab- 
oratory examinations included hemoglobin, free plasma rteriogra- 
phy, hematocrit, and coagulation parameters, both before, 
immediately after, and 24 hr after thrombectomy. Noninvasive 
examinations (oscillography, Doppler pressure recordings, duplex 
sonography) were performed after 48 hr and 3 months. Antegrade 
arteriography was performed via the common femoral artery to 
determine the length of occlusion, and to document the collateral 
circulation and the peripheral runoff. 
Using the road map technique the occlusion was passed with a 
Teflon-coated 0.020-inch guidewire and its flexible tip placed in the 
distal popliteal artery. An 8 Fr sheath was introduced and 5000 U 
of heparin injected. The thrombectomy catheter was threaded over 
the guidewire. One centimeter proximal to the upper end of the 
occlusion the catheter was activated by a foot switch and advanced 
through the occlusion in gentle forward and back movements under 
fluoroscopic control. The continuous suction of blood and occlusion 
material into the reservoir bag was observed. After the catheter had 
passed the occlusion it was withdrawn in the proximal femoral 
artery and angiography was repeated via the side port of the sheath. 
Depending on the result, thrombectomy was either terminated, 
repeated, or completed by percutaneous transluminal ngioplasty 
(PTA). The number and the duration of catheter passes and the 
volume of aspirated fluid were recorded. Extracted occlusion ma- 
terial was examined histologically. 
Results 
Preclinical Studies 
The catheter removed 48-hr-old thrombi n silicon tubing of 
4 and 6 mm diameter completely and regularly. The maxi- 
mum working diameter was 8 mm. On average 1 cm of 
thrombus was aspirated within 2 sec. Thrombi stored in the 
refrigerator for 2 weeks often showed adherence to the wall 
of the tubing, but could also easily be aspirated, leaving 
occasionally a thin residual ayer attached to the inner cur- 
vature if the tube was bent. Occlusion material of higher and 
inhomogeneous consistency, such as muscle, fat, and con- 
nective tissue, was caught readily in the catheter head and 
transported to the outside by the spiral. Fluid was aspirated 
at a rate of 1.5 ml/sec. While fresh thrombus was completely 
homogenized, more solid material was cut into particles of 
100-500 /xm. Strips of bovine arteries, sutured intralumi- 
nally to the vessel wall to imitate intimal flaps, were cut and 
fragmented, leaving only small stumps at the suture site. 
Bovine arteries filled with thrombi or "black pudding" could 
be cleared of the occlusion material without remnants. No 
intimal damage was noticed on visual examination or after 
staining. When the arteries were compressed to complete 
occlusion by a rubber band, the catheter drilled a lumen 
corresponding to its shaft size. When tubing or arteries were 
bent, the catheter followed the guidewire smoothly. No per- 
foration was noticed. 
The catheter needs fluid (blood) for lubrication. Under 
experimental conditions the temperature of the catheter head 
rose by t.5~ after rotating for 4 min at 40,000 rpm in a tube 
of 3-mm diameter perfused with a saline-glycerine solution 
(80 ml/min) at room temperature. 
Clinical Studies 
Thrombectomy was technically successful in all patients 
(Figs. 2, 3). A mean of 2.4 catheter passes (range 2-3) were 
required to recanalize the occluded segment, and 2.8 sec on 
average were needed to open 1 cm of occlusion. Blood and 
detritus were aspirated at 1.1 ml/sec; the total aspirated 
volume ranged from 20 to 90 ml, depending on the length 
and consistency of the lesion. In nine patients an underlying 
residual stenosis was treated by PTA after the thrombec- 
tomy. Forty-eight hours after the intervention o patient 
suffered from critical ischemia: eight patients were classified 
as PAOD stage I, and 2 patients as stage II. Ankle/brachial 
index (ABI) improved from 0.41 ___ 0.18 (range 0.13-0.65) 
preinterventionally to 0.88 __- 0.15 (range 0.64-1.11) after 
the intervention (p < 0.0005). Three months after the 
intervention the mean ABI was 0.84 + 0.20 (range 0.52- 
1.07). 
All patients received either oral anticoagulation or anti- 
platelet drugs and were assessed by duplex sonography 48 hr 
and 3 months after the intervention. The treated arterial 
segments remained patent in eight patients. Two patients had 
a reocclusion within 2 weeks after the intervention. In a 
60-year-old woman with an occlusion 3 cm long in a 
smoothly outlined superficial femoral artery of 5-mm diam- 
eter and with three patent lower leg vessels, fresh thrombus 
was removed with the Rotarex catheter in two passes of 7 
sec. Complete vessel patency was restored, no peripheral 
embolism occurred, and additional PTA was not considered 
to be indicated. As usual the patient received 5000 U of 
heparin during the intervention and oral anticoagulation af- 
terwards. After 48 hr duplex sonography revealed a reocclu- 
sion. At that time coagulation parameters were not in the 
y 
Fig. 2. A Angiogram of a 63-year-old woman with a history of percutaneous transluminal angioplasty (PTA) of a short subtotal 
occlusion of the superficial femoral artery (SFA) 3 months previously. She had been exhibiting signs of critical ischemia for 8 
days, the ankle/brachial index (ABI) was 0,14 and there was a 6-cm-long occlusion of the distal SFA. B After two passes with 
the thrombectomy device (2 x 10 sec) vessel patency has been restored; there is residual stenosis at 16 cm. C After additional 
PTA the stenosis was removed. The ABI was 0.91. 
Fig. 3. A Angiogram of a 78-year-old diabetic woman with rest pain. She had a 12-cm-long occlusion of the popliteal artery 
and of the tibiofibular trunk. B The artery was patent after one pass with the Rotarex catheter. C After additional PTA of the 
tibiofibular trunk and the anterior tibial artery. 
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therapeutic range, which might have contributed to the re- 
thrombosis. The ABI, which improved from 0.61 to 0.71 
after the intervention, remained at this level. The patient was 
classified as PAOD stage II without he need for a reinter- 
vention. The second patient was a 78-year-old iabetic 
woman with a history of claudication of several years, rest 
pain for 12 days and a 15-cm-long occlusion of the popliteal 
artery with poor lower leg outflow. Thrombectomy was 
primarily successful and complete vessel patency was re- 
stored after additional PTA. The ABI rose from 0.65 to 0.95 
and duplex sonography showed a residual stenosis of less 
than 50% diameter reduction. One week after hospital dis- 
charge the patient complained of recurrence of intermittent 
claudication and a reocclusion was documented. Since the 
patient was clinically in PAOD stage II no further interven- 
tion was performed. Reduced outflow due to pre-existing 
lower leg artery occlusions was considered as a possible 
cause for rethrombosis. 
No patient had signs of mechanical damage to red blood 
cells. There was no increase in free plasma hemoglobin, or 
relevant changes in hemoglobin and hematocrit after throm- 
bectomy. 
Histologic examination of the aspirate showed mostly 
fresh thrombotic material and small components of fibrotic 
intima with sclerotic fragments. No serious complications 
occurred. In one patient a small embolus was detected an- 
giographically within the proximal posterior tibial artery and 
lysed successfully by 100,000 units of urokinase. 
Discussion 
In the last decade great efforts have been made to provide an 
alternative to time-consuming local fibrinolysis and surgical 
thrombectomy in the treatment of intravascular thrombosis. 
Percutaneous a piration thrombectomy through thin-walled, 
straight catheters i still a common, readily available, simple 
and cost-effective t chnique for the removal of fresh thrombi 
[5]. Its restriction to loose, not adherent thrombi, the neces- 
sity of usually several passes, and the risk of plaque avulsion 
and antegrade dissection have, however, led to the construc- 
tion of more sophisticated devices [6]. The experience with 
the first catheter equipped with a fast-rotating, coaxially 
driven cam (Trac-Wright, formerly Kensey) was disappoint- 
ing. The device was, however, the predecessor f several 
generations of rotational catheters [7, 8]. These can roughly 
be classified into devices using recirculation, e.g., pulveri- 
zation of thrombi by a hydrodynamic vortex created either 
by a high-speed impeller [9-12] or the Venturi effect [13, 
14], and nonrecirculation catheters with concomitant suc- 
tion, using either a rotating recessed propeller [15, 16] or 
rotating cutting blades [17, 18] and aspiration via a roller 
pump or any other suction modality [19]. These devices are 
effective in clearing fresh thrombi, especially in arterial and 
hemodialysis grafts; however, their effectiviness decreases 
with the age of thrombi and their adherence to the vessel 
wall. Since many occlusions are "acute on chronic" throm- 
boses, a thrombectomy device should have the potential to 
remove not only fresh but also underlying organized throm- 
bus. Furthermore it should track over a guidewire in order to 
prevent vessel perforation. Finally it should transport he 
occlusion material to the outside without he risk of periph- 
eral embolization. 
The new catheter described here meets many of these 
requirements. Itsconstruction is relatively simple, using only 
one lumen for spiral and coaxial guidewire. No extra chan- 
nels for suction, lubrication, or cooling are needed. The 
transport of the occlusion material is done exclusively by the 
spiral. Some devices are easily obstructed by sticky occlu- 
sion material, especially by fibrin, which has to be trans- 
ported through narrow catheters over a distance of 80-100 
cm. In the new catheter this drawback was eliminated by a 
special coating of the spiral and by adjusting the rotational 
speed to 40,000 rpm. As with all rotating devices heat caused 
by friction can be a problem [20]. The new device needs 
blood for lubrication. Therefore it should not be advanced 
continuously in an occlusion, but in gentle forward and back 
movements, allowing the uninterrupted aspiration of blood 
and avoidance of running dry. Provided these precautions 
were observed, no undue warming of the catheter was noted. 
Average time for thrombectomy was short and did not ex- 
ceed 90 sec for occlusions up to 15 cm in length. Blood loss 
during thrombectomy is generally low, amounting to 80-90 
ml/min depending on the composition of the occlusion ma- 
terial that has to be transported and the blood available in the 
artery. 
A useful parameter for the assessment of the efficacy of a 
thrombectomy catheter is the radial expansion coefficient, 
i.e., the ratio of the lumen recanalized by thrombectomy to 
the catheter diameter. For the new catheter the coefficient is
2 in vitro, meaning that the catheter with a diameter of 
approximately 3 mm clears a thrombus of 6 mm. In vivo the 
radial expansion coefficient depends on the composition of 
the occlusion material. It is about 2 in fresh thrombi but 
drops to 1 in solid material, which means that the reopened 
lumen corresponds to the diameter of the catheter head. 
Experimental data suggest he use of the catheter for the 
treatment of obstructed vessels with a diameter up to 8 mm. 
This study showed its feasibility and efficacy in superficial 
femoral arteries of 4-7 mm diameter. Its applicability in 
larger vessels, such as pelvic arteries, vena cava, or pulmo- 
nary arteries, needs to be validated in further trials. 
Compared with other thrombectomy devices the potential 
of the Rotarex catheter to remove not only loose thrombus 
but also solid, organized occlusion material must be consid- 
ered an advantage. The catheter passes calcified plaques 
without abrading them. Therefore, adjunctive PTA after 
thrombectomy is often advisable to eliminate residual steno- 
sis. As shown in arterial models the wire-guided catheter 
removes thrombus without intimal abrasion if the original 
caliber of the artery is larger than the catheter head. Conse- 
quently the catheter in the 8 Fr version is not suitable for 
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thrombectomy in vessels distal to the popliteal artery. For 
use in small vessels a 5 Fr version is in preparation. 
Hemolysis occurs in recirculation catheters without aspi- 
ration, but its clinical effect seems minimal [21 ]. In our study 
no change in free plasma hemoglobin was noticed after 
thrombectomy. Except for a small embolus in a posterior 
tibial artery, which was removed by local fibrinolysis, no 
relevant complication occurred. It can be assumed that the 
negative pressure built up by the catheter system is sufficient 
to avoid peripheral embolization. The majority of our pa- 
tients suffered from "acute on chronic PAOD" and thus from 
thrombotic and not embolic occlusions. 
As expected from the preclinical tests, the catheter was 
easy to handle and helped to save considerable time by 
shortening thrombectomy to a few minutes and avoiding 
lengthy procedures uch as local fibrinolysis or surgical 
intervention. To document the efficacy and safety of the 
device further, a larger-scale multicenter study is required 
and is in progress. 
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